Inspiratory Muscle Therapy in Subjects With Fontan Circulations
A Pilot Study of Inspiratory Muscle Function and the Effects of Inspiratory Muscle Training in Subjects With Fontan Physiology
1 other identifier
interventional
7
0 countries
N/A
Brief Summary
Individuals who have undergone the Fontan procedure are uniquely dependent upon respiratory mechanics to support pulmonary blood flow (PBF). The investigators hypothesized that enhanced respiratory muscle function via inspiratory muscle training (IMT) would improve performance on cardiopulmonary exercise stress testing (CPET).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 24, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2017
CompletedFirst Submitted
Initial submission to the registry
October 18, 2017
CompletedFirst Posted
Study publicly available on registry
November 13, 2017
CompletedJanuary 29, 2024
January 1, 2024
7 months
October 18, 2017
January 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Exercise parameters
Peak VO2 and endurance time are the primary outcome measures
6-8 weeks
Study Arms (1)
Experimental arm - Inspiratory Muscle Training
EXPERIMENTALSingle arm study. All subjects will perform 6-8 weeks of inspiratory muscle therapy with cardiopulmonary stress test (both standard and constant work rate) before and after intervention.
Interventions
6 weeks of inspiratory muscle therapy
Eligibility Criteria
You may qualify if:
- Single ventricle physiology status post Fontan palliation
You may not qualify if:
- The presence of a sub-pulmonary ventricle
- Pregnancy or any contraindication to stress testing (e.g., uncontrolled symptomatic arrhythmia, severe systemic ventricular outflow tract obstruction or uncontrolled symptomatic heart failure).
- Height less than 4'11" due to limitations of the cycle ergometer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician Specialist
Study Record Dates
First Submitted
October 18, 2017
First Posted
November 13, 2017
Study Start
January 29, 2016
Primary Completion
August 24, 2016
Study Completion
August 31, 2017
Last Updated
January 29, 2024
Record last verified: 2024-01